First-in-man Trial Evaluating the Safety and Efficacy of the NOVA Intracranial Stent (NOVA Trial)
A trial with no phase registered on ClinicalTrials.gov. The registry status is completed. It enrolled 272 participants.
Also called NCT02578069
- Study
- In this atlas
Overview
- Design
- Interventional study; randomized; single masking; primary purpose treatment
- Phase
- Not applicable
- Enrolled
- 272 participants
- Registry
-
NCT02578069
-
- Other papers using this trial's data
- Comparison of Drug-Eluting Stent With Bare-Metal Stent in Patients With Symptomatic High-grade Intracranial Atherosclerotic Stenosis: A Randomized Clinical Trial
- Started
- (actual)
- Primary completion
- (actual)
- Completion
- (actual)
- Countries
- China
- Registry status
- Completed
Technical summary
Registry record NCT02578069. Randomized; single masking; primary purpose treatment. Start 2015-04-27 (actual); primary completion 2020-01 (actual). Results not posted.
The registry's words
Labels as the registry gives them, not rewritten.
- Brief title
- First-in-man Trial Evaluating the Safety and Efficacy of the NOVA Intracranial Stent (NOVA Trial)
- Acronym
- NOVA
- Condition
- Ischemic Stroke
- Intervention (Device)
- NOVA Intracranial Sirolimus Eluting Stent System
- Intervention (Device)
- Apollo Intracranial Stent System
- Lead sponsor
- Sino Medical Sciences Technology Inc.
- Collaborator
- Beijing Tiantan Hospital
Record details
- Record id
cardio:ct-nct02578069- Content hash
1fd0b48d69284a85821d294715475154fc91d577130b11222212cbd735eae4ba